Gabriela Nicolau
Corporate Officer/Principal at Tetragenex Pharmaceuticals, Inc.
Profile
Gabriela Nicolau is currently the Director of Pharmacokinetics & Drug Metabolism at Tetragenex Pharmaceuticals, Inc. She is also a member of the International Society for the Study of Xenobiotics.
In the past, she was a member of the National Academy of Sciences, Gordon Research Conferences, and Symposia Medicus.
Dr. Nicolau received a graduate degree from the University of Bucharest in 1966 and a doctorate degree from the same institution in 1968.
Gabriela Nicolau active positions
| Companies | Position | Start |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Corporate Officer/Principal | 04/02/2010 |
| International Society for the Study of Xenobiotics | Corporate Officer/Principal | 04/02/2010 |
Former positions of Gabriela Nicolau
| Companies | Position | End |
|---|---|---|
| Gordon Research Conferences | Corporate Officer/Principal | - |
Symposia Medicus
 Symposia Medicus Miscellaneous Commercial ServicesCommercial Services Symposia Medicus provides healthcare education services. | Corporate Officer/Principal | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | President | - |
Training of Gabriela Nicolau
| University of Bucharest | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
| Gordon Research Conferences | |
| International Society for the Study of Xenobiotics | |
Symposia Medicus
Symposia Medicus Miscellaneous Commercial ServicesCommercial Services Symposia Medicus provides healthcare education services. | Commercial Services |
- Stock Market
- Insiders
- Gabriela Nicolau
